Steady state phosphorus mass balance model during hemodialysis based on a pseudo one-compartment kinetic model

International Journal of Artificial Organs

Volumn 35, Issue 11, 2012, Pages 969-980

  Leypoldt, John K ^a   Agar, Baris U ^a   Akonur, Alp ^a   Gellens, Mary E ^a   Culleton, Bruce F ^a  

^a BAXTER HEALTHCARE CORPORATION   (United States)

Author keywords

Clearance; Dietary intake; Hemodialysis; Mass balance; Mathematical model; Phosphorus

Indexed keywords

BODY FLUIDS; HEMODIALYZERS; KINETIC PARAMETERS; KINETIC THEORY; PATIENT TREATMENT; PHOSPHORUS;

CLEARANCE; DIETARY INTAKES; HAEMODIALYSIS; KINETIC BALANCE; KINETIC MODELS; MASS BALANCE; MASS-BALANCE MODELING; PHOSPHORUS CONCENTRATION; PHOSPHORUS MASS BALANCES; STEADY STATE;

DIALYSIS;

PHOSPHORUS;

ARTICLE; COMPARTMENT MODEL; DIETARY INTAKE; HEMODIALYSIS; HUMAN; INTESTINE ABSORPTION; KIDNEY FUNCTION; KINETICS; PHOSPHATE BLOOD LEVEL; PHOSPHATE METABOLISM; PREDICTION; PSEUDO ONE COMPARTMENT KINETIC MODEL; SIMULATION; STEADY STATE MASS BALANCE MODEL; TREATMENT DURATION;

EID: 84867145412     PISSN: 03913988     EISSN: None     Source Type: Journal    
DOI: 10.5301/ijao.5000131     Document Type: Article

References (38)

1. Block GA, Hulbert-Shearon TE, Levin NW, Port FK. Association of serum phosphorus and calcium x phosphate product with mortality risk in chronic hemodialysis patients: a national study. Am J Kidney Dis. 1998;31(4):607-617.
2. Covic A, Kothawala P, Bernal M, Robbins S, Chalian A, Goldsmith D. Systematic review of the evidence underlying the association between mineral metabolism disturbances and risk of all-cause mortality, cardiovascular mortality and cardiovascular events in chronic kidney disease. Nephrol Dial Transplant. 2009;24(5):1506-1523.
3. Floege J, Kim J, Ireland E, et al. ARO Investigators. Serum iPTH, calcium and phosphate, and the risk of mortality in a European haemodialysis population. Nephrol Dial Transplant. 2011;26(6):1948-1955.
4. Naves-Díaz M, Passlick-Deetjen J, Guinsburg A, et al. Calcium, phosphorus, PTH and death rates in a large sample of dialysis patients from Latin America. The CORES Study. Nephrol Dial Transplant. 2011;26(6):1938-1947.
5. Palmer SC, Hayen A, Macaskill P, et al. Serum levels of phosphorus, parathyroid hormone, and calcium and risks of death and cardiovascular disease in individuals with chronic kidney disease: a systematic review and meta-analysis. JAMA. 2011;305(11):1119-1127.
6. Rufino M, de Bonis E, Martín M, et al. Is it possible to control hyperphosphataemia with diet, without inducing protein malnutrition? Nephrol Dial Transplant. 1998;13 (Suppl 3):65-67.
7. Moe SM, Zidehsarai M P, Chambers MA, et al. Vegetarian compared with meat dietary protein source and phosphorus homeostasis in chronic kidney disease. Clin J Am Soc Nephrol. 2011;6(2):257-264.
8. Sherman RA, Mehta O. Phosphorus and potassium content of enhanced meat and poultry products: implications for patients who receive dialysis. Clin J Am Soc Nephrol. 2009;4(8):1370-1373.
9. Sherman RA, Mehta O. Dietary phosphorus restriction in dialysis patients: potential impact of processed meat, poultry, and fish products as protein sources. Am J Kidney Dis. 2009;54(1):18-23.
10. Tonelli M, Pannu N, Manns B. Oral phosphate binders in patients with kidney failure. N Engl J Med. 2010;362(14): 1312-1324.
11. Agar BU, Akonur A, Cheung AK, Leypoldt JK. A simple method to estimate phosphorus mobilization in hemodialysis using only predialytic and postdialytic blood samples. Hemodial Int. 2011;15(Suppl 1):S9-S14.
12. Agar BU, Akonur A, Lo YC, Cheung AK, Leypoldt JK. Kinetic model of phosphorus mobilization during and after short and conventional hemodialysis. Clin J Am Soc Nephrol. 2011;6(12):2854-2860.
13. Gotch FA, Panlilio F, Sergeyeva O, et al. A kinetic model of inorganic phosphorus mass balance in hemodialysis therapy. Blood Purif. 2003;21(1):51-57.
14. Eloot S, Torremans A, De Smet R, et al. Kinetic behavior of urea is different from that of other water-soluble compounds: the case of the guanidino compounds. Kidney Int. 2005;67(4):1566-1575.
15. Basile C, Libutti P, Di Turo AL, et al. Removal of uraemic retention solutes in standard bicarbonate haemodialysis and long-hour slow-flow bicarbonate haemodialysis. Nephrol Dial Transplant. 2011;26(4):1296-1303.
16. Kerr PG, Lo A, Chin M, Atkins RC. Dialyzer performance in the clinic: comparison of six low-flux membranes. Artif Organs. 1999;23(9):817-821.
17. Katopodis K P, Chala A, Koliousi E, et al. Role of the dialyzer membrane on the overall phosphate kinetics during hemo-dialysis. Blood Purif. 2005;23(5):359-364.
18. Tonelli M, Wang W, Hemmelgarn B, Lloyd A, Manns B; Alberta Kidney Disease Network. Phosphate removal with several thrice-weekly dialysis methods in overweight hemodialysis patients. Am J Kidney Dis. 2009;54(6): 1108-1115.
19. Penne EL, van der Weerd NC, van den Dorpel MA, et al. CONTRAST Investigators. Short-term effects of online hemodiafiltration on phosphate control: a result from the randomized controlled Convective Transport Study (CONTRAST). Am J Kidney Dis. 2010;55(1):77-87.
20. Sugisaki H, Onohara M, Kunitomo T. Dynamic behavior of plasma phosphate in chronic dialysis patients. Trans Am Soc Artif Intern Organs. 1982;28:302-307.
21. Spalding EM, Chamney PW, Farrington K. Phosphate kinetics during hemodialysis: Evidence for biphasic regulation. Kidney Int. 2002;61(2):655-667.
22. Agar BU, Troidle L, Finkelstein FO, Kohn O F, Akonur A, Leypoldt JK. Patient-specific phosphorus mobilization clearance during nocturnal and short daily hemodialysis. Hemodial Int.
23. Agar BU, Leypoldt K, Akonur A, Hutchcraft A, Culleton B F. Determinants of phosphorus kinetic parameters during haemodialysis: Results from the HEMO Study. (Abstract). Nephrol Dial Transplant. 2012;27(Suppl 2):ii49.
24. Mucsi I, Hercz G, Uldall R, Ouwendyk M, Francoeur R, Pierratos A. Control of serum phosphate without any phosphate binders in patients treated with nocturnal hemo-dialysis. Kidney Int. 1998;53(5):1399-1404.
25. Ayus JC, Mizani MR, Achinger SG, Thadhani R, Go AS, Lee S. Effects of short daily versus conventional hemodialysis on left ventricular hypertrophy and inflammatory markers: a prospective, controlled study. J Am Soc Nephrol. 2005;16(9):2778-2788.
26. Ayus JC, Achinger SG, Mizani MR, et al. Phosphorus balance and mineral metabolism with 3 h daily hemodialysis. Kidney Int. 2007;71(4):336-342.
27. Troidle L, Hotchkiss M, Finkelstein F. A thrice weekly in-center nocturnal hemodialysis program. Adv Chronic Kidney Dis. 2007;14(3):244-248.
28. Bugeja A, Dacouris N, Thomas A, et al. In-center nocturnal hemodialysis: another option in the management of chronic kidney disease. Clin J Am Soc Nephrol. 2009;4(4):778-783.
29. Vaithilingam I, Polkinghorne KR, Atkins RC, Kerr PG. Time and exercise improve phosphate removal in hemodialysis patients. Am J Kidney Dis. 2004;43(1):85-89.
30. Penne EL, van der Weerd NC, Grooteman M P, et al. CONTRAST investigators. Role of residual renal function in phosphate control and anemia management in chronic hemo-dialysis patients. Clin J Am Soc Nephrol. 2011;6(2):281-289.
31. Sigrist MK, Devlin L, Taal MW, Fluck RJ, McIntyre CW. Length of interdialytic interval influences serum calcium and phosphorus concentrations. Nephrol Dial Transplant. 2005;20(8):1643-1646.
32. Daugirdas JT, Chertow GM, Larive B, et al. Frequent He-modialysis Network (FHN) Trial Group. Effects of frequent hemodialysis on measures of CKD mineral and bone disorder. J Am Soc Nephrol. 2012;23(4):727-738.
33. Tentori F, Blayney MJ, Albert JM, et al. Mortality risk for dialysis patients with different levels of serum calcium, phosphorus, and PTH: the Dialysis Outcomes and Practice Patterns Study (DOPPS). Am J Kidney Dis. 2008;52(3): 519-530.
34. Gotch FA, Panlilio F, Sergeyeva O, et al. Effective diffusion volume flow rates (Qe) for urea, creatinine, and inorganic phosphorous (Qeu, Qecr, QeiP) during hemodialysis. Semin Dial. 2003;16(6):474-476.
35. Bhimani J P, Ouseph R, Ward RA. Effect of increasing dialy-sate flow rate on diffusive mass transfer of urea, phosphate and beta2-microglobulin during clinical haemodialysis. Nephrol Dial Transplant. 2010;25(12):3990-3995.
36. Sargent JA, Gotch FA. Mathematic modeling of dialysis therapy. Kidney Int. 1980;18(Suppl 10):S2-S10.
37. th edition. Dordrecht: Kluwer Academic;1996:34-102.
38. DeSoi CA, Umans JG. Phosphate kinetics during high-flux hemodialysis. J Am Soc Nephrol. 1993;4(5):1214-1218.